• Friday, May 29, 2020 @ 12:00 am

For its first clinical trial in the EU on TOP-N53, a healing therapy for diabetic foot ulcer (DFU), Topadur Pharma Germany GmbH, located at Georges-Köhler-Str. 2 in Lörrach, Germany, was entered in the company register in May 2020.

Dr. Reto Näf and Dr. Christian Ludin act as managing directors.

You may also be interested in